By Professor Jason Grebely

Journal articles

Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019

Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015

Grebely J; Knight E; Genoway K; Viljoen M; Khara M; Elliott D; Gallagher L; Storms M; Raffa J; DeVlaming S; Duncan F; Conway B, 2010, 'Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support', European Journal of Gastroenterology and Hepatology, 22, pp. 270 - 277

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Grebely J; Knight E; Ngai T; Genoway K; Raffa J; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B, 2010, 'Reinfection with hepatitis C virus following sustained virological response in injection drug users', Journal of Gastroenterology and Hepatology, 25, pp. 1281 - 1284, http://dx.doi.org/10.1111/j.1440-1746.2010.06238.x

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; Van Beek I; Kaldor J; Dore GJ, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', DRUG AND ALCOHOL REVIEW, 28, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B, 2009, 'Primary drug resistance in antiretroviral-naïve injection drug users', International Journal of Infectious Diseases, 13, pp. 577 - 583, http://dx.doi.org/10.1016/j.ijid.2008.08.028

Grebely J; Thomas D; Dore GJ, 2009, 'HCV reinfection studies and the door to vaccine development', Journal of Hepatology, 51, pp. 628 - 631

Grebely J; Raffa J; Krajden M; Kerr TH; Fischer B; Tyndall M, 2009, 'Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents', Journal of Viral Hepatitis, 16, pp. 352 - 358

Brooke R; Tang P; Mak A; Grebely J; Adie K; Danta M; Spinelli J; Andonov A; Krajden M, 2009, 'P214 Molecular epidemiology of newly acquired hepatitis C virus (HCV) infections in British Columbia', International Journal of Antimicrobial Agents, 34, pp. S95 - S95, http://dx.doi.org/10.1016/s0924-8579(09)70433-9

Tossonian H; Raffa J; Grebely J; Viljoen M; Mead A; Khara M; Mclean M; Krishnamurthy A; DeVlaming S; Conway B, 2009, 'Primary drug resistance in chronically infected antiretroviral-naïve injection drug users.', International Journal of Infectious Diseases, 13, pp. 577 - 583

Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B, 2009, 'Reinfection with hepatitis C virus following sustained virological response in injection drug users', Journal of Gastroenterology and Hepatology, pp. no - no, http://dx.doi.org/10.1111/j.1440-1746.2009.06238.x

Conway B; Tossonian H; Raffa J; Storms M; Duncan F; Grebely J, 2009, 'Systematic approach to the treatment of HCV infection in injection drug users: where are we now?', Future Virology, 4, pp. 411 - 413, http://www.futuremedicine.com/

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072

Grebely J; Raffa JD; Lai C; Kerr T; Krajden M; Kerr T; Dore GJ; Tyndall MW, 2008, 'Impact of HCV and HIV infections on mortality in a large community-based cohort of inner city residents', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23, pp. A379 - A380, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Raffa JD; Tossonian HK; Grebely J; Petkau AJ; Devlaming S; Conway B, 2008, 'Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations', Journal of Acquired Immune Deficiency Syndromes, 47, pp. 397 - 399, http://dx.doi.org/10.1097/QAI.0b013e31815b0d35

Grebely J; Devlaming S; Duncan F; Viljoen M; Conway B, 2008, 'Current approaches to HCV infection in current and former injection drug users', Journal of Addictive Diseases, 27, pp. 25 - 35, http://dx.doi.org/10.1300/J069v27n02_04

Grebely J; Genoway KA; Raffa JD; Dhadwal G; Rajan T; Showler G; Kalousek K; Duncan F; Tyndall MW; Fraser C; Conway B; Fischer B, 2008, 'Barriers associated with the treatment of hepatitis C virus infection among illicit drug users', Drug and Alcohol Dependence, 93, pp. 141 - 147, http://dx.doi.org/10.1016/j.drugalcdep.2007.09.008

Grebely J; Gallagher L; Knight E; Genoway K; Storms M; Tossonian HK; Hosseina M; Showler G; Raffa JD; Fraser C; Duncan F; Conway B, 2008, 'Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH', Journal of the International AIDS Society, 11, pp. P277 - P277, http://dx.doi.org/10.1186/1758-2652-11-s1-p277

Matthews G; Grebely J; Dore GJ, 2008, 'The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure', Journal of Hepatology, 49, pp. 305 - 307, http://dx.doi.org/10.1016/j.jhep.2008.06.005

Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B, 2007, 'Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection', International Journal of Drug Policy, 18, pp. 437 - 443, http://dx.doi.org/10.1016/j.drugpo.2007.01.009

Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B, 2007, 'The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program', Drug and Alcohol Dependence, 89, pp. 306 - 309, http://dx.doi.org/10.1016/j.drugalcdep.2007.02.007

Tossonian HK; Raffa JD; Grebely J; Trotter B; Viljoen M; Mead A; Khara M; McLean M; Duncan F; Fraser C; DeVlaming S; Conway B, 2007, 'Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program', Journal of Acquired Immune Deficiency Syndromes, 45, pp. 324 - 327, http://dx.doi.org/10.1097/QAI.0b013e318061b5fd

Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW, 2007, 'Reply [2]', Hepatology, 45, pp. 1331, http://dx.doi.org/10.1002/hep.21602

Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; Devlaming S; Conway B, 2007, 'Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapy', The open virology journal, 1, pp. 8 - 13, http://dx.doi.org/10.2174/1874357900701010008

Grebely J; Raffa JD; Meagher C; Duncan F; Genoway KA; Khara M; McLean M; Mead A; Viljoen M; DeVlaming S; Fraser C; Conway B, 2007, 'Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users', Journal of Gastroenterology and Hepatology (Australia), 22, pp. 1519 - 1525, http://dx.doi.org/10.1111/j.1440-1746.2007.05032.x

Crebely J; Raffa JD; Lai C; Krajden M; Conway B; Tyndall MW, 2007, 'Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users', Canadian Journal of Gastroenterology, 21, pp. 447 - 451, http://dx.doi.org/10.1155/2007/796325

Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW, 2006, 'Hepatitis C virus reinfection in injection drug users', Hepatology, 44, pp. 1139 - 1145, http://dx.doi.org/10.1002/hep.21376

Conway B; Grebely J; Duncan F, 2006, 'Time for a systematic approach to the treatment of hepatitis C virus infection in injection drug users', FUTURE VIROLOGY, 1, pp. 139 - 141, http://dx.doi.org/10.2217/17460794.1.2.139

Grebely J; Conway B; Raffa J; Lai C; Krajden M; Tyndall MW, 2006, 'Uptake of hepatitis C virus (HCV) treatment among injection drug users (IDUS) in Vancouver, Canada', JOURNAL OF HEPATOLOGY, 44, pp. S214 - S215, http://dx.doi.org/10.1016/S0168-8278(06)80578-7

Conway B; Grebely J; Tossonian H; Lefebvre D; De Vlaming S, 2005, 'A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: A Canadian perspective', Clinical Infectious Diseases, 41, http://dx.doi.org/10.1086/429500

Conference Papers

Bharat C; Webb P; Wilkinson Z; McKetin R; Grebely J; Farrell M; Holland A; Hickman M; Tran LT; Clark B; Peacock A; Darke S; Li J-H; Degenhardt L, 2023, 'Agreement between self-reported illicit drug use and biological samples: A systematic review and meta-analysis', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S41 - S42

Webb P; Ireland J; Colledge-Frisby S; Ottaviano S; Grebely J; Wheeler A; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L, 2023, 'Global patterns of drug use among people who inject drugs', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S183 - S184

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop AJ; Dore GJ; McDonough M; Montebello ME; Weiss R; Rodgers C; Cook J; Degenhardt L, 2023, 'Ninety-six week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a singlearm trial', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S72 - S73

Clay S; Treloar C; Degenhardt L; Grebely J; Farrell M; Marshall AD, 2022, 'Options: Exploring patients' experiences with depot buprenorphine and their motivations to discontinue', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J, 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', in International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Grebely J; Marshall AD, 2021, '"WE'VE HAD A CIRCUIT BREAKER FOR AN OLD DOGMA OF MORE THAN 20 YEARS": CHANGES TO OPIOID AGONIST TREATMENT SERVICES DURING COVID-19, THE CHOICE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Amin J; Christmass M; Dunlop AJ; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Dore GJ; Treloar C; Grebely J, 2021, 'OPIOID OVERDOSE AND NALOXONE ACCESS AMONG PEOPLE WHO RECENTLY USED OPIOIDS OR RECEIVED OPIOID AGONIST TREATMENT IN AUSTRALIA: THE ETHOS ENGAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Casey J; MacParland S; Zahoor A; Janssen HLA; Matthews G; Marks P; Grebely J; Dore G; Hansen BE; Kaul R; Chua C; Gehring AJ; Feld JJ, 2020, 'RESTORATION OF HCV-SPECIFIC T CELLS FOLLOWING DAA THERAPY IN ACUTE HCV INFECTION-SUPPORT FOR TREATMENT OF ACUTE INFECTION.', in HEPATOLOGY, WILEY, ELECTR NETWORK, pp. 613A - 614A, presented at Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 November 2020 - 16 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000574027002142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Marshall AD; Grebely J; Dore GJ; Treloar C, 2019, 'BARRIERS AND FACILITATORS TO ENGAGING IN HEPATITIS C MANAGEMENT AND DIRECT-ACTING ANTIVIRAL THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND ALCOHOL SPECIALISTS: THE PRACTITIONER EXPERIENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S9 - S9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Artenie AA; Cunningham E; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Applegate TL; Dillon JF; Fraser C; Gane E; Litwin AH; Marks P; Matthews GV; Quiene S; Thurnheer MC; Weltman M; Dore G; Bruneau J; Grebely J, 2018, 'Drug and alcohol use patterns during and following treatment with sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use: Insights from trajectory analyses', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, pp. 31 - 32, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lamoury F; Bajis S; Martinez D; Mowat Y; Jayasinghe I; Martinez M; Cunningham P; Catlett B; Jacka B; Marks P; Grebely J; Cloherty G; Dore G; Applegate T, 2018, 'Evaluation of a hepatitis C virus core antigen assay in dried-blood spots: a cohort study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S317 - S318, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30854-7

Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'Evaluation of the Xpert fingerstick HCV viral load assay', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S167 - S167, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30546-4

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin N; Mchutchison JG; Brainard D; Treloar C; Lloyd A; Dore G, 2018, 'Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S187 - S188, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30587-7

Grebely J; Feld JJ; Wyles D; Sulkowski MS; Ni L; Llewellyn J; Mir H; Sajed N; Stamm LM; Hyland R; McNally J; Brainard D; Jacobson I; Zeuzem S; Bourliere M; Foster G; Afdhal N; Dore GJ, 2017, 'EFFICACY AND SAFETY OF SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRAL THERAPIES FOR HEPATITIS C VIRUS INFECTION IN PATIENTS RECEIVING OPIOID SUBSTITUTION THERAPY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 34 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dore GJ; Grebely J; Altice F; Litwin AH; Dalgard O; Gane EJ; Shibolet O; Conway B; Nahass R; Luetkemeyer A; Peng C-Y; Iser DM; Gendrano IN; Kelly MM; Huang H-C; Hwang P; Barr E; Robertson M; Platt H, 2017, 'Hepatitis C Virus (HCV) Reinfection and Injecting Risk Behavior Following Elbasvir (EBR)/Grazoprevir (GZR) Treatment in Participants on Opiate Agonist Therapy (OAT): Co-STAR Part B', in HEPATOLOGY, WILEY, DC, Washington, pp. 112A - 113A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089800196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31900-1

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; Mchutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S274 - S274, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30862-0

Cunningham EB; Hajarizadeh B; Amin J; Bretana NA; Luciani F; Degenhardt L; Larney S; Dore GJ; Lloyd AR; Grebely J, 2017, 'Injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting, 2005-2014: the HITS-p study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S488 - S488, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31370-3

Grebely J, 2017, 'ENHANCING HEPATITIS C VIRUS TESTING, LINKAGE TO CARE AND DIRECT-ACTING ANTIVIRAL TREATMENT FOR PEOPLE WHO INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 16 - 16

Back to profile page